Key facts
- Ruize Health’s last known valuation is $10.8M (Feb 2024).
- It has raised $1.4M; the latest was Early Stage VC in Mar 2026.
- Notable investors include Marathon Venture Partners, China Life Reinsurance Company, Cenova Capital, Guangzhou Yaobang Information Technology, Yaoshibang.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Ruize Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Ruize Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ruize Health
Operator of an online pharmacy marketplace designed for purchasing prescription and over-the-counter medicines. The company provides curated assortments and transparent pricing, enabling consumers with convenient purchase and delivery solutions.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Shanghai, China
- Founded
- 2023
- Website
- ruizehealth.com.cn/
- Ownership
- Privately Held (backing)
Ruize Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ruize Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ruize Health in its N-PORT filings yet. We sweep new filings monthly.